D. Sparks

M. Leboyer, D. Sparks, D. Sparks, 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease?

D. Sparks, 1997, Annals of the New York Academy of Sciences.

Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients

D. Sparks, S. Scheff, F. Danner, 1996, Journal of the Neurological Sciences.

Link between heart disease, cholesterol, and Alzheimer's disease: A review

D. R. Gross, D. Sparks, T. Martin, 2000, Microscopy research and technique.

The Pineal Gland in Sudden Infant Death Syndrome: Preliminary Observations

D. Sparks, D. Sparks, J. Hunsaker, 1988, Journal of pineal research.

Statin therapy in Alzheimer's disease

D. Sparks, D. Connor, M. Sabbagh, 2006, Acta neurologica Scandinavica. Supplementum.

Increased density of cortical apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol

D. R. Gross, D. Sparks, S. Scheff, 1995, Neuroscience Letters.

Alterations of Alzheimer's Disease in the Cholesterol‐fed Rabbit, Including Vascular Inflammation: Preliminary Observations

D. Sparks, T. Martin, R. Lukas, 2000, Annals of the New York Academy of Sciences.

Hippocampal volume change in the Alzheimer Disease Cholesterol-Lowering Treatment trial.

Sterling C. Johnson, L. Baxter, D. Sparks, 2008, Cleveland Clinic journal of medicine.

Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol‐Lowering Treatment (ADCLT) trial

D L Sparks, D. Sparks, D. Connor, 2006, Acta neurologica Scandinavica. Supplementum.

Cholesterol and Cognition

D. Sparks, R. Martins, T. Martin, 2002 .

HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier.

D. Sparks, D. Connor, M. Sabbagh, 2002, The journal of nutrition, health & aging.

Length of stay in skilled nursing facilities is longer for patients with dementia.

D. Sparks, D. Connor, M. Sabbagh, 2003, Journal of Alzheimer's disease : JAD.

Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension

D. Sparks, S. Scheff, Huaichen Liu, 1995, Journal of the Neurological Sciences.

Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease

D. Sparks, W. Markesbery, S. Scheff, 1990, Neurobiology of Aging.

Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs

D. R. Gross, D. Sparks, D. Sparks, 2000, Neurobiology of Aging.

Cholesterol, copper and statin therapy in Alzheimer's disease

C. Adler, D. Sparks, Jean E Lopez, 2005 .

Tau is reduced in AD plasma and validation of employed ELISA methods.

D. Sparks, M. Sabbagh, R. Kryscio, 2012, American journal of neurodegenerative disease.

Temporal Sequence of Plaque Formation in the Cerebral Cortex of Non-Demented Individuals

D. Sparks, S. Scheff, Huaichen Liu, 1993, Journal of neuropathology and experimental neurology.

Quantitative assessment of possible age-related change in synaptic numbers in the human frontal cortex

D. Sparks, S. Scheff, D. Price, 2001, Neurobiology of Aging.

Immunohistochemical localization of nicotinic β2 and α4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations

D. Sparks, T. Beach, R. Lukas, 1998, Neuroscience Letters.

Postmortem changes in the levels and localization of microtubule‐associated proteins (tau, MAP2 and MAP1B) in the rat and human hippocampus

D. Sparks, D. Sparks, J. Geddes, 1994, Hippocampus.

Reduced risk of incident AD with elective statin use in a clinical trial cohort.

D. Sparks, D. Connor, M. Sabbagh, 2008, Current Alzheimer research.

Neurovascular changes measured by time‐of‐flight MR angiography in cholesterol‐fed rabbits with cortical amyloid β‐peptide accumulation

B. Schreurs, D. Sparks, J. Carpenter, 2010, Journal of magnetic resonance imaging : JMRI.

Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).

C. Adler, D. Sparks, Jean E Lopez, 2005, Current Alzheimer research.

The early and ongoing experience with the cholesterol-fed rabbit as a model of Alzheimer's disease: the old, the new and the pilot.

D. Sparks, 2008, Journal of Alzheimer's disease : JAD.

Cholesterol increases ventricular volume in a rabbit model of Alzheimer's disease.

D. Sparks, B. Schreurs, D. Sparks, 2012, Journal of Alzheimer's disease : JAD.

Sudden Infant Death Syndrome: Altered Aminergic-Cholinergic Synaptic Markers in Hypothalamus

D. Sparks, D. Sparks, J. Hunsaker, 1991, Journal of child neurology.

Altered striatal dopaminergic metabolism 36 hours after unilateral trauma to the human mesencephalon

D. Sparks, D. Sparks, S. DeKosky, 1987, Neurology.

Classical conditioning of the rabbit's nictitating membrane response is a function of the duration of dietary cholesterol

D. Sparks, B. Schreurs, D. Sparks, 2007, Nutritional neuroscience.

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

Patrick Browne, Lenore J Launer, Jean Lopez, 2005, Archives of neurology.

Alzheimer'S disease: Monoamines and spiperone binding reduced in nucleus basalis

D. Sparks, D. Sparks, W. Markesbery, 1986, Annals of neurology.

Statins to treat Alzheimer’s disease: an incomplete story

D. Sparks, Marwan N. Sabbagh, 2012, Expert review of neurotherapeutics.

Monoaminergic and Cholinergic Synaptic Markers in the Nucleus Basalrs

D. Sparks, W. Markesbery, J. Slevin, 2004 .

A position paper

D. Sparks, M. Sabbagh, J. Seward, 2007, Journal of Molecular Neuroscience.